Showing results (261-270 of 330) with videos related to
Sort By:
Pageof 33
Human Pathology|February 15, 2001
Interobserver reproducibility of Gleason grading of prostatic carcinoma: general pathologistW C Allsbrook, K A Mangold, M H Johnson, et al.Journal of Neurosurgery|March 1, 1995
Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomasK D Judy, A Olivi, K G Buahin, et al.The American Journal of Pathology|May 1, 1996
Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancersM Krajewska, S Krajewski, J I Epstein, et al.Progress in Clinical and Biological Research|January 1, 1989
The value of prostate-specific antigen in the management of localized prostatic cancerP C Walsh, J E Oesterling, J I Epstein, et al.American Journal of Clinical Pathology|October 1, 1986
Localized herpes simplex lymphadenitisJ I Epstein, R F Ambinder, F P Kuhajda, et al.Ophthalmology|January 1, 1990
Ophthalmic involvement in aggressive histiocytosis XM W MacCumber, P N Hoffman, G S Wand, et al.Cancer|July 1, 1992
Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancerA W Partin, G D Steinberg, R V Pitcock, et al.The American Journal of Surgical Pathology|August 10, 2000
Primary renal synovial sarcoma: molecular and morphologic delineation of an entity previously included among embryonal sarcomas of the kidneyP Argani, P A Faria, J I Epstein, et al.International Journal of Cancer|December 5, 2000
Papillary urothelial hyperplasia is a clonal precursor to papillary transitional cell bladder cancerN H Chow, P Cairns, C F Eisenberger, et al.Cancer Research|February 15, 1993
Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancerA W Partin, R H Getzenberg, M J CarMichael, et al.Pageof 33